• Bone Health
  • Immunology
  • Hematology
  • Respiratory
  • Dermatology
  • Diabetes
  • Gastroenterology
  • Neurology
  • Oncology
  • Ophthalmology
  • Rare Disease
  • Rheumatology

Julianne Orr, PharmD: Biosimilars Still a Gray Area for Pharmacists

Video

Julianne Orr, outpatient oncology clinical pharmacist, Indiana University Health, explains that biosimilars remain a gray area for pharmacists.

Transcript:

What is your understanding of the use of biosimilars?

I know it’s a hot topic; I know I’ve been to quite a few [continuing education sessions, CEs] on it. At [Indiana University] it has not been necessarily a big topic of discussion. We have pretty much stuck with the products we’ve been using. But I think in the future, hopefully with more knowledge of biosimilars and everything we can kind of define a clear cut “when we should use what,” and how we interchange those products. It’s definitely a gray area at the moment.

Recent Videos
Josh Canavan, PharmD, head of pharmacy at RazorMetrics
Tiago Biachi, MD, PhD
Elie Bahou, MD, PhD
Steve Pickette, PharmD
Sophia Humphreys, PharmD
Sophia Humphreys, PharmD
Ivo Abraham, PhD, RN.
Ivo Abraham, PhD, RN.
Ivo Abraham, PhD, RN.
Ivo Abraham, PhD, RN.
Related Content
© 2025 MJH Life Sciences

All rights reserved.